Parkinson Pipeline Project-treatment development database, research, FDA drug approval, PD clinical trials and sponsors, patient involvement

Therapy Issues

Date	*Title*	Author
	Patient Enrollment completed for Phase IIb Clinical Study of Spheramine (6/28/07)
	Does PD itself or treatments for it increase risk of developing malignant melanoma?
	Questions and Answers About "Off-Label" Use of Prescription Drugs	W. H. DeCamp, Parkinson Pipeline Project L. Herman, Parkinson Pipeline Project, Therapies Coordinator July 24, 2007